BNGO vs EYPT

Bionano Genomics, Inc. vs EyePoint, Inc. — Valuation Comparison 2026

BNGO

Laboratory Analytical Instruments
Bionano Genomics, Inc.
Quality
6.0
out of 10
Value Trap
39
LOW
Price
$1.24
Last close
Models
10/13
Active
VS

EYPT

Laboratory Analytical Instruments
EyePoint, Inc.
Quality
5.6
out of 10
Value Trap
12
SAFE
Price
$13.58
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType BNGO Fair ValueBNGO Upside EYPT Fair ValueEYPT Upside
Bayesian DCF Intrinsic $0.25 -79.6% $3.76 -72.3%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.50 -59.6% $1.76 -87.0%
Dynamic NAV Asset-Based $5.99 +382.7% $4.13 -69.6%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for BNGO vs EYPT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BNGO vs EYPT — Which Stock Is More Undervalued?

BNGO scores higher with a 6.0/10 quality rating vs EYPT's 5.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Bionano Genomics, Inc. (BNGO) and EyePoint, Inc. (EYPT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BNGO currently trades at $1.24 with a QOC of 6.0/10, while EYPT trades at $13.58 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).